Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy
AbstractTheranostics is an integrated nanosystem that combines therapeutics with diagnostics in attempt to develop new personalized treatments with enhanced therapeutic efficacy and safety. As a promising therapeutic paradigm with cutting-edge technologies, theranostic agents are able to simultaneously deliver therapeutic drugs and diagnostic imaging agents and also monitor the response to therapy. Polymeric nanosystems have been intensively explored for biomedical applications to diagnose and treat various cancers. In recent years, glycol chitosan-based nanoagents have been developed as dual-purpose materials for simultaneous diagnosis and therapy. They have shown great potential in cancer therapies, such as chemotherapeutics and nucleic acid and photodynamic therapies. In this review, we summarize the recent progress and potential applications of glycol chitosan-based fluorescent theranostic nanoagents for cancer treatments and discuss their possible underlying mechanisms. View Full-Text
Scifeed alert for new publicationsNever miss any articles matching your research from any publisher
- Get alerts for new papers matching your research
- Find out the new papers from selected authors
- Updated daily for 49'000+ journals and 6000+ publishers
- Define your Scifeed now
Rhee, J.-K.; Park, O.K.; Lee, A.; Yang, D.H.; Park, K. Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy. Mar. Drugs 2014, 12, 6038-6057.
Rhee J-K, Park OK, Lee A, Yang DH, Park K. Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy. Marine Drugs. 2014; 12(12):6038-6057.Chicago/Turabian Style
Rhee, Jin-Kyu; Park, Ok K.; Lee, Aeju; Yang, Dae H.; Park, Kyeongsoon. 2014. "Glycol Chitosan-Based Fluorescent Theranostic Nanoagents for Cancer Therapy." Mar. Drugs 12, no. 12: 6038-6057.